Loading...
Projects source: E-CRIS

Advanced technologies for controlled release from solid drug delivery systems

Research activity

Code Science Field
P176  Natural sciences and mathematics  Artificial intelligence 
T150  Technological sciences  Material technology 
T350  Technological sciences  Chemical technology and engineering 
T410  Technological sciences  Pharmaceuticals and related technologies 
Keywords
solid dosage forms, controlled release, bioavailability, optimization
Organisations (2) , Researchers (1)
0007  University of Belgrade, Faculty of Pharmacy
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  03196  Svetlana Ibrić  Pharmaceuticals and related technologies  Head  2011 - 2019  219 
0170  Galenika JSC (IRC)
Abstract
The aim of this project is to develop products and technologies with controlled drug release properties from solid dosage forms. Excipients and techniques that enhance solubility/modify drug release rate and intestinal absorption will be investigated. Within the project, characterization of model drugs and excipients will be performed (determination of solubility, polymorphic forms, particle size, and in vitro dissolution). In the first project phase, poorly soluble drugs drug(s) will be complexed using cyclodextrins, and treated using spray-drying or lyophilization technique. Tablet forming properties of obtained drug complexes will be investigated.The second phase of the project includes preparation of solid dispersions with poorly soluble drugs and various solvents, monitoring of changes in drug polymorphic forms and characterization of solid dispersion. The third phase of the project represents development of fluidized hot-melt granulation technique using. In the fourth phase of the research the potential for the preparation of selfmicroemulsifying therapeutic systems will be studied. Selfemulsifying properties will be characterized and obtained systems further adsorbed on biocompatible microcarriers, Drug release from adsorbates will be studied. Formulation and processes will be optimized using artificial neural networks. Gastrointestinal simulations will be used to develop understanding and assess factors that influence bioavailability of poorly soluble drugs.
Views history
Favourite